Evidence map›Paper›PMID 29259781›Full record

ReviewF1000Research2017

Fragile X syndrome and fragile X-associated disorders.

Akash Rajaratnam, Jasdeep Shergill, Maria Salcedo-Arellano, Wilmar Saldarriaga, Xianlai Duan, Randi Hagerman

Open access · goldAbstract readReview
In one paragraph

Review in F1000Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Dysregulation of BMP, Wnt, and Insulin Signaling in Fragile X Syndrome.Frontiers in cell and developmental biology · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Molecular analysis ofPractical laboratory medicine · 2020
    Article
  17. Article
  18. Mechanisms underlying auditory processing deficits in Fragile X syndrome.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 3 countries.

Akash RajaratnamMIND Institute, UC Davis Health, Sacramento, CA, USA.
Jasdeep ShergillMIND Institute, UC Davis Health, Sacramento, CA, USA.
Maria Salcedo-ArellanoMIND Institute, UC Davis Health, Sacramento, CA, USA.
Wilmar SaldarriagaMIND Institute, UC Davis Health, Sacramento, CA, USA.
Xianlai DuanMIND Institute, UC Davis Health, Sacramento, CA, USA.
Randi HagermanMIND Institute, UC Davis Health, Sacramento, CA, USA.ORCID https://orcid.org/0000-0002-8026-6559
UC Davis Health · US

Funding

GENOTYPE/PHENOTYPE RELATIONSHIPS IN FRAGILE X FAMILIESR01HD036071 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI PAUL J HAGERMAN, RANDI J. HAGERMAN · 1998 to 2026
$13.8M
Rodent Behavior CoreU54HD079125 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SIMON, TONY J · 2013 to 2019
$8.5M
NICHD NIH HHS R01 HD036071NICHD NIH HHS U54 HD079125
6 · The paper itself

Abstract

Fragile X syndrome (FXS) is caused by a full mutation on the

Indexed as

copy number variantsFMR1 genepoint mutationswhole exome sequencing

Identifiers

PMID29259781
PMCPMC5728189
OpenAlexW2773097171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.